Effects of Glucagon‐Like Peptide‐1 Receptor Agonists (Mono and Combination Therapy) on Energy Expenditure: A Scoping Review
Acute or chronic GLP-1RA monotherapy does not appear to impact EE independent of weight loss. Combining GLP-1RA with glucagon or GIP may impact EE in different ways, requiring further exploration.
Authors
- Flávio Tavares Vieira
- Sarah Cawsey
- Manfred James Müller (ORCID: https://orcid.org/0000-0002-7280-2411)
- ANDREA HAQQ
- Carla M. Prado (ORCID: https://orcid.org/0000-0002-3609-5641)
- Zhidi Deng
- Melania Manco
- Giovanna G L Bergamasco
- Steven B Heymsfield
Institutions
- Pennington Biomedical Research Center (US)
- Louisiana State University (US)
- University of Alberta (CA)
- Hochschule für Angewandte Wissenschaften Kiel (DE)
- Bambino Gesù Children's Hospital (IT)
Publication Details
- Journal
- Obesity Reviews
- Published
- 2026-03-04
- DOI
- https://doi.org/10.1111/obr.70116
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00